Research Paper Volume 10, Issue 1 pp 115—130

HOXC6 predicts invasion and poor survival in hepatocellular carcinoma by driving epithelial-mesenchymal transition


Figure 2. Overall survival and time to recurrence are shown for patients with HCC. All patients were classified according to tumor size, vascular invasion, TNM stage and BCLC stage. Kaplan-Meier survival estimates and log-rank tests were used to analyze the prognostic value of HOXC6 expression in all patients (A) and each subgroup (B-I).